NCT00389389View on ClinicalTrials.gov

Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions

Neoplasms

Interventions

DRUG

AZD4877

intravenous infusion

Trial Locations (3)

Unknown

Research Site, Denver

Research Site, Nashville

Research Site, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY